REFERENCES
- Emit ® d.a.u. Cannabinoid 20 Assay and Emit® s.t. Cannabinoid Assay package inset issued 1984. Syva Company, Palo Alto, CA 94303.
- Abuscreen radioimmunoassay for cannabi- noids (125I). Roche Diagnostic Systems, Division of Hoffman-La Roche Inc., Nutley, NJ, 07110 package insert issued October 1983.
- Meatherall RC, Garriott JC. A sensitive thin layer chromatographic procedure for the detection of urinary 11-nor- Δ9-tetrahydrocannabinol-9-carboxylic acid. J. Anal. Toxicol. 1988; 12: 136–140.
- Sutheimer CA, Yarborough R, Hepler BR, Sunshine I. Detection and confirmation of urinary cannabinoids. J. Anal. Toxicol. 1985; 9: 156–160.
- Whiting JD, Manders WW. The confirmation of 39-carboxy-THC in urine by gas chromatography/mass-spectrometry. Aviat. Space Environ. Med. 1983; 54: 1031–1033.
- Garriott JC, DiMaio VJM, Rodriquez RG. Detection of cannabinoids in homicide victims and motor vehicle fatalities. J. Forensic Sci. 1986; 31: 1274–1282.
- Cannabinoids Assay, TDx System Assays Manual, issued March, 1987. Abbott Laboratories, Chicago, IL, 60064.
- Law B, Mason PA, Moffat AC, King LJ. A novel 125I radioimmunoassay for the analysis of Δ9-tetrahydrocannabinol and its metabolites in human body fluids. J. Anal. Toxicol. 1984; 8: 14–18.
- Karlsson L, Ström M. Laboratory evaluation of the TDx assay for detection of cannabinoids in urine from prison inmates. J. Anal. Toxicol. 1988; 12: 310–321.
- Leavitt RK, Miehm VL, Timmings SD, Beaumier PM. An evaluation of the selectivity of the Roche Abuscreen, Syva Emit®-d.a.u. and Abbott TDx for the analysis of urinary cannabinoids. International Association of Forensic Toxicologists, 24th International Meeting, July 27–31, 1987, Banff, Alberta Canada, and by personal communication with Dr. Leavitt.
- Perez-Reyes M, DiGuiseppi S, Mason AP, Davis KH. Passive inhalation of marijuana smoke and urinary excretion of cannabinoids. Clin. Pharmacol. Ther. 1983; 34: 36–41.
- Peat MA. THCA calibrators and controls. J. Anal. Toxicol. 1988; 12, 239.
- Cesamet (nabilone) product monograph issued September, 1981. Eli Lilly Canada Inc. Toronto, Ontario.
- Ward A, Holmes B. Nabilone —A preliminary review of its pharmacological properties and therapeutic use. Drugs 1985; 30: 127–144.